EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in de novo coronary chronic total occlusion intervention: A multicenter observational study

Xi Wang, Xinyue Yang, Wenjie Lu, Liang Pan, Zhanying Han, Sancong Pan, Yingguang Shan, Xule Wang, Xiaolin Zheng, Ran Li, Yongjian Zhu, Peng Qin und 10 weitere

Frontiers in Cardiovascular Medicine · 03.03.2023 · 10

DOI: 10.3389/fcvm.2023.1045859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 03.03.2023. Verfasst von Xi Wang und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data on drug-coated balloons (DCB) for de novo coronary chronic total occlusion (CTO) are limited. We aimed to investigate the long-term outcomes of substitution of drug-eluting stents (DES) by DCB.

Methods

We compared the outcomes of less DES strategy (DCB alone or combined with DES) and DES-only strategy in treating de novo coronary CTO in this prospective, observational, multicenter study. The primary endpoints were major adverse cardiovascular events (MACE), target vessel revascularization, myocardial infarction, and death during 3-year follow-up. The secondary endpoints were late lumen loss (LLL) and restenosis until 1-year after operation.

Results

Of the 591 eligible patients consecutively enrolled between January 2015 and December 2019, 281 (290 lesions) were treated with DCB (DCB-only or combined with DES) and 310 (319 lesions) with DES only. In the DCB group, 147 (50.7%) lesions were treated using DCB-only, and the bailout stenting rate was relatively low (3.1%). The average stent length per lesion in the DCB group was significantly shorter compared with the DES-only group (21.5 ± 25.5 mm vs. 54.5 ± 26.0 mm, p < 0.001). A total of 112 patients in the DCB group and 71 patients in the DES-only group (38.6% vs. 22.3%, p < 0.001) completed angiographic follow-up until 1-year, and LLL was much less in the DCB group (−0.08 ± 0.65 mm vs. 0.35 ± 0.62 mm, p < 0.001). There were no significant differences in restenosis occurrence between the two groups (20.5% vs. 19.7%, p > 0.999). The Kaplan–Meier estimates of MACE at 3-year (11.8% vs. 12.0%, log-rank p = 0.688) was similar between the groups.

Conclusion

Percutaneous coronary intervention with DCB is a potential “stent-less” therapy for de novo CTO lesions with satisfactory long-term clinical results compared to the DES-only approach.

Schlagwörter

Stichwörter der Autor:innen

chronic total occlusioncoronary heart diseasedrug-coated balloondrug-eluting stentpercutaneous coronary intervention

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Cardiovascular Medicine, Jincheng People's Hospital, Jincheng, China.
  • Department of Geriatric Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Cardiology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Zitieren

APA

Wang, X., Yang, X., Lu, W., Pan, L., Han, Z., Pan, S., Shan, Y., Wang, X., Zheng, X., Li, R., Zhu, Y., Qin, P., Shi, Q., Zhou, S., Zhang, W., Guo, S., Zhang, P., Qin, X., Sun, G., …, & Qiu, C. (2023). Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in de novo coronary chronic total occlusion intervention: A multicenter observational study. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1045859

Vancouver

Wang X, Yang X, Lu W, Pan L, Han Z, Pan S, et al. Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in de novo coronary chronic total occlusion intervention: A multicenter observational study. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1045859

BibTeX
@article{Wang2023,
  author = {Wang, Xi and Yang, Xinyue and Lu, Wenjie and Pan, Liang and Han, Zhanying and Pan, Sancong and Shan, Yingguang and Wang, Xule and Zheng, Xiaolin and Li, Ran and Zhu, Yongjian and Qin, Peng and Shi, Qiangwei and Zhou, Shuai and Zhang, Wencai and Guo, Sen and Zhang, Peisheng and Qin, Xiaofei and Sun, Guoju and Qin, Zhongsheng and Huang, Zhenwen and Qiu, Chunguang},
  title = {Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in de novo coronary chronic total occlusion intervention: A multicenter observational study},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2023},
  volume = {10},
  doi = {10.3389/fcvm.2023.1045859}
}
Kostenlos starten →